Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Harris

Showing results (1481-1490 of 1,850) with videos related to

Pageof 185
Sort By:
JTO Clinical and Research Reports|November 25, 2022
The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective StudyDavid J Benjamin, Shuai Chen, Joanna B Eldredge, et al.
Animal Genetics|January 22, 2014
Genomic analysis of the differential response to experimental infection with porcine circovirus 2bA M McKnite, J W Bundy, T W Moural, et al.
Animal : an International Journal of Animal Bioscience|April 14, 2018
Roles of instrumented farm-scale trials in trade-off assessments of pasture-based ruminant production systemsT Takahashi, P Harris, M S A Blackwell, et al.
Development (Cambridge, England)|June 12, 2016
The FaceBase Consortium: a comprehensive resource for craniofacial researchersJames F Brinkley, Shannon Fisher, Matthew P Harris, et al.
Cancers|February 13, 2026
Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001Elena Gabriela Chiorean, Sheela R Damle, David B Zhen, et al.
Hepatology (Baltimore, Md.)|November 10, 2025
A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinomaAnthony B El-Khoueiry, Richard D Kim, William P Harris, et al.
JCO Oncology Practice|December 15, 2025
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisAmy H Huang, Gin Yi Lee, Chuan Angel Lu, et al.
British Journal of Cancer|November 14, 2018
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinomaVincenzo Mazzaferro, Bassel F El-Rayes, Michele Droz Dit Busset, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|April 28, 2009
Safety of high-dose corticosteroids for the treatment of autoimmune inner ear diseaseThomas H Alexander, Michael H Weisman, Jennifer M Derebery, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 19, 2012
Audiology in the sudden hearing loss clinical trialChris Halpin, Helen Shi, Domenic Reda, et al.
Pageof 185

Showing results (1481-1490 of 1,850) with videos related to

Sort By:
Pageof 185
JTO Clinical and Research Reports|November 25, 2022
The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective StudyDavid J Benjamin, Shuai Chen, Joanna B Eldredge, et al.
Animal Genetics|January 22, 2014
Genomic analysis of the differential response to experimental infection with porcine circovirus 2bA M McKnite, J W Bundy, T W Moural, et al.
Animal : an International Journal of Animal Bioscience|April 14, 2018
Roles of instrumented farm-scale trials in trade-off assessments of pasture-based ruminant production systemsT Takahashi, P Harris, M S A Blackwell, et al.
Development (Cambridge, England)|June 12, 2016
The FaceBase Consortium: a comprehensive resource for craniofacial researchersJames F Brinkley, Shannon Fisher, Matthew P Harris, et al.
Cancers|February 13, 2026
Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001Elena Gabriela Chiorean, Sheela R Damle, David B Zhen, et al.
Hepatology (Baltimore, Md.)|November 10, 2025
A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinomaAnthony B El-Khoueiry, Richard D Kim, William P Harris, et al.
JCO Oncology Practice|December 15, 2025
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisAmy H Huang, Gin Yi Lee, Chuan Angel Lu, et al.
British Journal of Cancer|November 14, 2018
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinomaVincenzo Mazzaferro, Bassel F El-Rayes, Michele Droz Dit Busset, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|April 28, 2009
Safety of high-dose corticosteroids for the treatment of autoimmune inner ear diseaseThomas H Alexander, Michael H Weisman, Jennifer M Derebery, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 19, 2012
Audiology in the sudden hearing loss clinical trialChris Halpin, Helen Shi, Domenic Reda, et al.
Pageof 185